Ovid Therapeutics (OVID) Stock Chart & Stock Price History → Healthcare Takes A Big Step Forward With The Help Of AI (From The Bull Report) (Ad) Free OVID Stock Alerts $3.32 0.00 (0.00%) (As of 01:34 PM ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Ovid Therapeutics Stock Price Performance5 Day Performance+10.67%1 Month Performance+4.73%3 Month Performance-13.54%6 Month Performance+1.53%Year-To-Date Performance+3.11%1 Year Performance-5.14% Receive OVID Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Ovid Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Banyan Hill PublishingForget the “Magnificent 7” Tech Companies, Buy This AI Stock InsteadThe AI boom continues to snowball with no signs of slowing... Google CEO, Sundar Pichai, made waves during a recent call with analysts, reminding them that the search engine company has been “AI first” since 2016.Get the full story here. OVID Stock Chart for Thursday, May, 16, 2024 OVID Chart by TradingView Ovid Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/15/2024$3.23$3.32+2.79%$3.43$3.18155,028 shs$235.09 million05/14/2024$3.02$3.23+6.95%$3.25$2.99122,716 shs$228.72 million05/13/2024$3.00$3.02+0.67%$3.04$2.9969,595 shs$213.85 million05/10/2024$3.05$3.00-1.64%$3.06$3.0054,455 shs$212.43 million05/09/2024$3.09$3.05-1.29%$3.10$3.0199,248 shs$215.97 million05/08/2024$3.00$3.09+3.00%$3.11$2.9899,242 shs$218.80 million Get the Latest News and Ratings for OVID and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Ovid Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 05/07/2024$3.02$3.00-0.66%$3.07$2.9898,708 shs$212.43 million05/06/2024$3.06$3.02-1.31%$3.14$2.99101,375 shs$213.85 million05/03/2024$3.07$3.06-0.33%$3.17$3.0077,108 shs$216.68 million05/02/2024$3.06$3.07+0.33%$3.12$3.0367,110 shs$217.39 million05/01/2024$3.05$3.06+0.33%$3.12$2.91222,034 shs$216.68 million04/30/2024$3.34$3.05-8.68%$3.45$3.04240,074 shs$215.97 million04/29/2024$3.10$3.34+7.74%$3.36$3.15311,342 shs$236.51 million04/26/2024$2.99$3.10+3.68%$3.13$2.9980,519 shs$219.20 million04/25/2024$3.15$2.99-5.08%$3.14$2.99112,117 shs$211.42 million04/24/2024$3.20$3.15-1.56%$3.22$3.11113,127 shs$222.74 million04/23/2024$3.15$3.20+1.59%$3.24$3.11110,579 shs$226.27 million04/22/2024$3.23$3.15-2.48%$3.29$3.12205,925 shs$222.74 million04/19/2024$3.21$3.23+0.62%$3.29$3.17176,627 shs$228.39 million04/18/2024$3.11$3.21+3.22%$3.24$3.12226,837 shs$226.98 million04/17/2024$3.17$3.11-1.89%$3.21$3.05160,463 shs$219.91 million04/16/2024$3.20$3.17-0.94%$3.23$3.16137,993 shs$224.15 million04/15/2024$3.20$3.20$3.24$3.20131,931 shs$226.27 million04/12/2024$3.27$3.20-2.14%$3.24$3.1388,254 shs$226.27 million04/11/2024$3.18$3.27+2.83%$3.29$3.1976,631 shs$231.22 million04/10/2024$3.24$3.18-1.85%$3.21$3.11167,577 shs$224.86 million04/09/2024$3.22$3.24+0.62%$3.32$3.20136,252 shs$229.10 million04/08/2024$3.25$3.22-0.92%$3.27$3.2056,495 shs$227.69 million04/05/2024$3.05$3.25+6.56%$3.35$3.06186,042 shs$229.81 million04/04/2024$3.05$3.05$3.15$3.0593,200 shs$215.67 million04/03/2024$3.05$3.05$3.09$3.0389,498 shs$215.67 million04/02/2024$3.09$3.05-1.29%$3.12$3.00200,076 shs$215.67 million04/01/2024$3.05$3.09+1.31%$3.17$3.05150,955 shs$218.49 million03/29/2024$3.05$3.05$3.17$3.04144,551 shs$215.67 million03/28/2024$3.05$3.05$3.17$3.04144,537 shs$215.67 million03/27/2024$3.00$3.05+1.67%$3.12$3.00169,934 shs$215.67 million03/26/2024$3.09$3.00-2.91%$3.22$3.00239,291 shs$212.13 million03/25/2024$3.20$3.09-3.44%$3.27$3.05170,865 shs$218.49 million03/22/2024$3.05$3.20+4.92%$3.38$3.06439,443 shs$226.27 million03/21/2024$2.79$3.05+9.32%$3.22$2.95440,241 shs$215.67 millionHealthcare Takes A Big Step Forward With The Help Of AI (Ad)The average doctor can diagnose an illness correctly 50-90% of the time. But one innovative company's medical AI gets it right 92%+.Click here to see why this small company is trusted by the Mayo Clinic03/20/2024$2.75$2.79+1.45%$2.87$2.602.59 million shs$197.28 million03/19/2024$2.73$2.75+0.73%$2.80$2.70290,842 shs$194.45 million03/18/2024$2.72$2.73+0.37%$2.78$2.69272,979 shs$193.04 million03/15/2024$2.75$2.72-1.09%$2.97$2.64546,936 shs$192.33 million03/14/2024$2.82$2.75-2.48%$2.89$2.71165,290 shs$194.45 million03/13/2024$2.83$2.82-0.35%$2.86$2.73202,557 shs$199.40 million03/12/2024$2.94$2.83-3.74%$3.04$2.80172,789 shs$200.02 million03/11/2024$3.08$2.94-4.55%$3.10$2.9294,929 shs$207.80 million03/08/2024$3.17$3.08-2.84%$3.23$3.0795,778 shs$217.69 million03/07/2024$3.25$3.17-2.46%$3.39$3.1561,028 shs$224.06 million03/06/2024$3.27$3.25-0.61%$3.31$3.2155,583 shs$229.71 million03/05/2024$3.34$3.27-2.10%$3.36$3.23100,999 shs$231.12 million03/04/2024$3.40$3.34-1.76%$3.39$3.2671,272 shs$236.07 million03/01/2024$3.40$3.40$3.45$3.31116,003 shs$240.31 million02/29/2024$3.43$3.40-0.87%$3.52$3.30300,942 shs$240.31 million02/28/2024$3.63$3.43-5.51%$3.64$3.42537,905 shs$242.43 million02/27/2024$3.68$3.63-1.36%$3.77$3.5788,644 shs$256.57 million02/26/2024$3.70$3.68-0.54%$3.79$3.6862,501 shs$260.11 million02/23/2024$3.68$3.70+0.54%$3.75$3.66145,497 shs$261.52 million02/22/2024$3.57$3.68+3.08%$3.77$3.62227,122 shs$260.10 million02/21/2024$3.72$3.57-4.03%$3.70$3.5352,251 shs$252.33 million02/20/2024$3.84$3.72-3.12%$3.85$3.6384,537 shs$262.93 million02/19/2024$3.84$3.84$3.93$3.64133,600 shs$271.41 million02/16/2024$3.64$3.84+5.49%$3.93$3.64133,648 shs$271.41 million02/15/2024$3.77$3.64-3.45%$3.91$3.59312,379 shs$257.28 million Related Companies: ATOS Stock Price Chart GBIO Stock Price Chart OMER Stock Price Chart RENB Stock Price Chart RIGL Stock Price Chart GALT Stock Price Chart MACK Stock Price Chart TRVI Stock Price Chart GTHX Stock Price Chart LFCR Stock Price Chart Receive OVID Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Ovid Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:OVID) was last updated on 5/16/2024 by MarketBeat.com Staff From Our PartnersHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportBiden to Drop BOMBSHELL June 13th?Paradigm PressElon to Transform U.S. Economy? Porter & CompanyCharles Payne Demystifies OptionsUnstoppable ProsperityThe most important AI company you've never heard ofManward PressThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyElon’s New Device is About to Shock the WorldInvestorPlaceGold ManiaStansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ovid Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.